FIELD: virology.
SUBSTANCE: invention relates to the use of the pharmaceutical substance Dorogov's antiseptic-stimulant fraction 2 (ASD-2F) as an agent having antiviral activity against influenza A and SARS-CoV-2 viruses.
EFFECT: expansion of the range of medicinal products with antiviral activity made in Russia.
1 cl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DIINDOLYLMETHANE DRUG PREPARATION AND USING IT FOR TREATING INFLUENZA AND RESPIRATORY VIRAL INFECTIONS | 2013 |
|
RU2537025C1 |
| METHODS OF PREVENTION AND TREATMENT OF DISEASES CAUSED BY A/H5N1 BIRD INFLUENZA VIRUS WITH USING INTERFERON INDUCER AND NEURAMINIDASE INHIBITOR | 2008 |
|
RU2398596C2 |
| VACCINE AGAINST INFLUENZA TYPE A, INFLUENZA TYPE B AND COVID-19 | 2021 |
|
RU2751485C1 |
| STRAIN OF INFLUENZA VIRUS B/NOVOSIBIRSK/40/2017-MA FOR STUDYING THERAPEUTIC AND PREVENTIVE EFFICACY OF ANTIVIRAL PREPARATIONS IN VITRO AND IN VIVO | 2019 |
|
RU2703024C1 |
| DRUG FOR TREATMENT OF INFECTIOUS DISEASES | 2019 |
|
RU2778522C2 |
| ANTIVIRAL HUMIC AGENT | 2020 |
|
RU2753609C1 |
| HYDRATED N-FULLERENE-AMINO ACID DERIVATIVES, METHOD FOR PREPARING THEM AND BASED PHARMACEUTICAL COMPOSITIONS | 2011 |
|
RU2458046C1 |
| SODIUM SALT OF 2-METHYLTHIO-6-CYANO-1,2,4-TRIAZOLO[5,1-C]-1,2,4-TRIAZIN-7(4H)-ONE, TRIHYDRATE | 2015 |
|
RU2607628C1 |
| RECOMBINANT INFLUENZA VIRUS INTENDED FOR THE PREVENTION OF COVID-19 AND INFLUENZA, METHOD OF ITS PRODUCTION AND USE | 2022 |
|
RU2802058C1 |
| METHOD OF TREATING AVIAN INFLUENZA | 2012 |
|
RU2502512C2 |
